Dr. Sascha Berger currently serves as the Investment Director for Biotech at NEOM, where leadership in global biotech and medtech investments is complemented by nearly two decades of industry experience. Concurrently, Sascha functions as an angel investor for Pangea Botanica and Invitris. Prior experience includes a significant tenure as General Partner at TVM Capital Life Science, where Sascha played a crucial role in raising a $480 million fund, leading multiple investments exceeding $100 million, and serving on the boards of various portfolio companies. Additionally, Sascha has held board positions and lead investor roles in several startups including Vektor Medical, myo, Mage Biologics, LAmAb Biologics, EGG medical, and T7 Therapeutics. Educational credentials include a Master's in Technology Management from the Technical University of Munich, a Doctorate in Banking from Technische Universität Chemnitz, and various other academic pursuits in innovation management and venture capital.
This person is not in any teams
This person is not in any offices